CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Intrigma

Intrigma is a leader in medical scheduling solutions that deliver bottom-line impact to medical groups, hospitals and hospital systems.

Essilor Canada

Essilor Canada Ltd. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

McLaren Regional Medical Center

McLaren Regional Medical Center is a Flint, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Luma Health

Needing healthcare can be hard — getting care shouldnt be. We built Luma Health because we are all patients. We believe it should be easy to see and connect with our doctor. To get the care we need, when we need it. Ours is a new vision aligned around letting systems deliver high-quality healthcare, lower the burden on staff, and provide the modern, mobile-first experience we all deserve.

Abbott Medical Optics

Abbott Medical Optics Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Abbott Medical Optics Inc. is based in Santa Ana, CA. You can find more information on Abbott Medical Optics Inc. at www.amo-inc.com